News

SonALAsense Pioneers Sonodynamic Therapy, a First-in-Class Noninvasive Therapy for Lethal Brain Cancers; Enters Into a Collaboration and License Agreement With Insightec and a Collaboration Agreement with Ivy Brain Tumor Center to Conduct the First-in-Man
December 31, 2020
Non-Invasive Drug-Device Treatment Aims to Target Brain Cancers Selectively, Turning them from Lethal Diseases into Manageable Conditions: Led by Experts with Decades of Experience Developing and Commercializing Drug-Device Systems in Photodynamic…
New Embolic Device Used in Interventional Oncology for Highly Targeted Tumor Treatment
November 23, 2020
Novel Interventional Oncology Embolization Device Successfully Used in Trans-Radial Access Procedures for Tumor Devascularization
ESMO ASIA Congress 2020 | CStone Pharmaceuticals announces the results of GEMSTONE-302, Sugemalimab has the potential to provide a new treatment option for patients with advanced NSCLC
November 23, 2020
CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on developing and commercializing innovative immuno-oncology (IO) therapies and precision medicines, today announced that positive clinical data based on a…
Innovent Releases Phase 3 Results of TYVYT® (Sintilimab Injection) in Combination with BYVASDA® (Bevacizumab Biosimilar Injection) as First-Line Treatment in Patients with Advanced Hepatocellular Carcinoma (HCC) at ESMO ASIA Virtual Congress 2020
November 23, 2020
ORIENT-32 is the first randomized Phase 3 study reporting the efficacy and safety of an anti-PD-1 antibody-based combination therapy versus sorafenib as the first-line treatment in patients with advanced unresectable hepatocellular carcinoma (HCC).
The University of Verona and IntraOp® Announce PancFORT Trial for Pancreatic Cancer
November 19, 2020
New Study explores clinical benefits of electron-beam IORT in the treatment of borderline resectable pancreatic cancer.
Varian and the Cincinnati Children's/UC Health Proton Therapy Center Announce Initial Patient Treated in the FAST-01 First Human Clinical Trial of FLASH Therapy for Cancer
November 19, 2020
FLASH therapy delivers radiation at ultra-high dose rates up to 100 times faster compared to conventional radiation therapy. The first patient in the world to participate in a clinical trial of FLASH therapy has been enrolled.
LSN Receives FDA Clearance For Virtual Liver Biopsy Software
November 18, 2020
This first FDA clearance represents a significant milestone for AI Metrics, where researchers have been seeking new ways to use CT scans for virtual liver biopsy. 
GT Medical Technologies Announces First Patient Treated in Registry Trial of GammaTile Therapy for Brain Tumors
November 10, 2020
Study to Enroll 600 Patients and Evaluate Real-World Clinical and Patient Reported Outcomes Across All Brain Tumor Types
icotec ag Receives FDA Clearance for the VADER® Pedicle - System with Bone Cement Augmentation
November 10, 2020
icotec announces the U.S. FDA 510(k) clearance to market the VADER® Pedicle - System for use with bone cement for augmentation or without.
Quest Announces that OncoQuest Pharmaceuticals Inc. Doses First Patient in Phase 3 Clinical Trial, FLORA-5, of Company's Lead Investigational Drug, Oregovomab, in Frontline Ovarian Cancer and appoints Dr. Sunil Gupta as Chief Medical Officer
November 09, 2020
OncoQuest Pharmaceuticals, Inc., has begun dosing patients in the USA for the Phase 3 clinical trial of its immunotherapeutic drug candidate oregovomab.
New Research Study Supports Clinical Utility of Circulating Tumor Cell Count for Metastatic Breast Cancer
November 09, 2020
First randomized clinical trial demonstrating that CTC count may help personalize treatment choices 
Back to Top